MediMix Dermatology
  • Home
  • Congresses
    • EADV 2025
    • EADV 2024
  • Contact
  • Other specialties
    • Hematology
    • Oncology
    • Respirology
  • SIGN UP
  • SIGN IN
    • Login
EADV 2025

Non-invasive imaging in male genital lesions

1 October 2025

Presented by Dr Lucas Boussingault (Erasme hospital Brussels, Belgium)

Dr Lucas Boussingault, dermatology resident at Erasme hospital in Brussels performed a retrospective analysis on LC-OCT images obtained prior to biopsy in twenty male patients presenting with penile erythematous lesions. Preliminary findings suggest that inflammatory dermatoses display characteristic LC-OCT patterns, enabling differentiation between entities such as balanitis and lichen planus. Most importantly, LC-OCT improves the ability to identify suspicious lesions requiring biopsy, particularly in cases where carcinoma may clinically mimic inflammation.

Although this study is limited by its small sample size and retrospective design, the results highlight the promise of LC-OCT as a non-invasive diagnostic adjunct in male genital dermatology. Larger, prospective studies are warranted to validate disease-specific imaging patterns and to establish the role of LC-OCT in guiding biopsy decisions.

References:

Boussingault L. et al. EADV2025; P1160

Back to EADV 2025

You may also be interested in:

Coop private-hospital

Update on cutaneous lupus

Vexas syndrome: what dermatologists should know

Made possible with the financial support of our partners.
All videos are developed independently and are non-promotional.

Tags:

poster

Share Article

MediMix Dermatology

Website created by MediMix © 2025 - Privacy Policy

MediMix Dermatology

Zandvoortstraat 21, Mechelen, Belgium

Website created by MediMix © 2024 - Privacy Policy

  • Home
  • Congresses
    • EADV 2025
    • EADV 2024
  • Contact
  • Other specialties
    • Hematology
    • Oncology
    • Respirology
  • SIGN UP
  • SIGN IN
    • Login
    • Logout
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.